LivaNova PLC BDR (L2IV34)

Currency in BRL
54.60
0.00(0.00%)
Closed·
Trading near 52-week High
L2IV34 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
54.6054.60
52 wk Range
41.6454.60
Key Statistics
Prev. Close
54.6
Open
54.6
Day's Range
54.6-54.6
52 wk Range
41.64-54.6
Volume
-
Average Vol. (3m)
4
1-Year Change
50.7454%
Book Value / Share
128.82
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
L2IV34 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low P/E ratio relative to near-term earnings growth

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy

Earnings

Latest Release
Nov 04, 2026
EPS / Forecast
0.11 / --
Revenue / Forecast
393.1M / --
EPS Revisions
Last 90 days

L2IV34 Income Statement

Compare L2IV34 to Peers and Sector

Metrics to compare
L2IV34
Peers
Sector
Relationship
P/E Ratio
25.6x15.8x−0.2x
PEG Ratio
0.140.160.00
Price / Book
3.7x2.6x2.6x
Price / LTM Sales
3.3x2.2x2.8x
Upside (Analyst Target)
-35.9%62.1%
Fair Value Upside
Unlock29.7%9.5%Unlock

LivaNova PLC, a medical technology company, designs, develops, manufactures, markets, and sells products, therapies, and services. The company operates in two segments, Cardiopulmonary and Neuromodulation. The Cardiopulmonary segment provides cardiopulmonary products, including heart-lung machines, oxygenators, autotransfusion systems, perfusion tubing systems, cannula, and other related accessories, as well as services related products. The Neuromodulation segment offers VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve, surgical equipment to assist with the implant procedure, and equipment and instruction manuals; and devices that deliver neuromodulation therapy for treating drug-resistant epilepsy and depression. This segment also includes the development and clinical testing of aura6000 system for treating obstructive sleep apnea. It serves perfusionists, neurologists, neurosurgeons, hospitals, other healthcare professionals and medical institutions, and healthcare providers. The company sells its medical devices through direct sales representatives, agents, and independent distributors in the United States, the United Kingdom, Germany, France, Italy, the Netherlands, Spain, Belgium, Poland, Sweden, Switzerland, Austria, Norway, Portugal, Finland, Denmark, and internationally. LivaNova PLC was incorporated in 2015 and is headquartered in Gloucester, the United Kingdom.

Industry
-
Sector
-
Employees
3300
Market
Brazil

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
37.12M67.37%2.03B
Other Institutional Investors
28.03M32.63%1.53B
Public Companies & Retail Investors
0.000.00%0.00
Total
65.15M100.00%3.56B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
BlackRock, Inc.13.73%7,565,342413,068
PRIMECAP Management Company7.57%4,168,377227,593

FAQ

What Is the LivaNova BDR (L2IV34) Stock Price Today?

The LivaNova BDR stock price today is 54.60 BRL.

What Stock Exchange Does LivaNova BDR Trade On?

LivaNova BDR is listed and trades on the B3 Stock Exchange.

What Is the Stock Symbol for LivaNova BDR?

The stock symbol for LivaNova BDR is "L2IV34."

What Is the LivaNova BDR Market Cap?

As of today, LivaNova BDR market cap is 27.62B BRL.

What Is LivaNova BDR's Earnings Per Share (TTM)?

The LivaNova BDR EPS (TTM) is 18.49.

From a Technical Analysis Perspective, Is L2IV34 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.

How Many Times Has LivaNova BDR Stock Split?

LivaNova BDR has split 0 times.

How Many Employees Does LivaNova BDR Have?

LivaNova BDR has 3300 employees.

What is the current trading status of LivaNova BDR (L2IV34)?

As of Nov 06, 2026, LivaNova BDR (L2IV34) is trading at a price of 54.60 BRL, with a previous close of 54.60 BRL. The stock has fluctuated within a day range of 54.60 BRL to 54.60 BRL, while its 52-week range spans from 41.64 BRL to 54.60 BRL.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.